CS Paper Radar

STEP: A Modular Silent Trial Engine for Operational Evaluation of Digital Pathology AI in Routine Workflow

Gabriele Campanella, Matthew Croken, Olga Lukatskaya, Jane Houldsworth, Ricky Kwan, Peter Schüffler, Chad Vanderbilt

cs.SE cs.CV ·submitted 2026-08-27 20:33 UTC · v1

Abstract

Prospective silent trials provide an important bridge between retrospective validation of artificial intelligence (AI) models and their use in clinical care by evaluating model performance and operational reliability on live clinical data without influencing patient management. In computational pathology, conducting silent trials requires integration across laboratory information systems, digital pathology infrastructure, computational resources, and model inference pipelines, and these workflows are often implemented using application-specific software. We developed the Silent Trial Engine for Pathology (STEP), a reusable software platform for orchestrating prospective silent trials of computational pathology AI models across heterogeneous clinical and computational environments. STEP separates common trial orchestration from institution-specific data access and compute infrastructure through modular adapter interfaces. The platform supports scheduled case discovery, per-slide inference submission, deterministic idempotency, failure recovery, result and ancillary-data ingestion, persistent trial and run state, and audit logging, with compute adapters supporting local execution and high-performance computing environments using LSF and Slurm. STEP was deployed at three institutions to support prospective silent evaluation of EAGLE, an AI model for predicting EGFR mutation status from hematoxylin and eosin-stained whole-slide images. By separating trial-level workflow logic from site-specific integrations, STEP enables a common execution framework to operate across heterogeneous pathology environments while maintaining durable and auditable trial state. This approach may reduce duplicated engineering effort and facilitate systematic real-world evaluation of computational pathology AI before interventional clinical deployment.

Closest papers

Nearest neighbours by meaning across the whole index.

TIAgent: From Natural Language to Grounded Agentic Workflows for Computational Pathology

cs.AI q-bio.QMcs.CLcs.MA ·2026-09-30 ·Aakash Madhav Rao, Mark Eastwood, Danielle Belgrave, Fayyaz Minhas
benchmark similarity 0.68
Abstract

Computational pathology (CPath) analyses increasingly depend on multi-step computational workflows that require substantial programming expertise, limiting their accessibility to pathologists and other domain experts without extensive coding experience. Although large language models (LLMs) provide a promising natural-language interface for constructing such analyses, hallucinated operations and incorrect workflow specifications limit their reliability in scientific settings. We introduce Tissue Image Analysis Agent (TIAgent), an automated CPath workflow generation framework that, given a natural-language prompt specifying a complex analytical task together with an input dataset, automatically constructs a verifiable computational graph employing existing CPath operations. The resulting graph can be inspected and executed, enabling natural-language construction of complex CPath workflows for applications including automated biomarker discovery and tissue analysis. We demonstrate end-to-end workflow generation and execution and systematically benchmark 14 backbone LLMs across 90 unit tasks spanning 18 CPath operation types. The ability of each LLM to generate a complete and correct unit workflow is quantified using Unit Workflow Success (UWS). Performance varied substantially across backbone models, with Kimi-K2.7-Code achieving the highest UWS of 0.967 (95% CI: 0.907-0.989). Analysis of node and parameter correctness further revealed that selecting the appropriate computational operation and correctly configuring it represent distinct challenges for LLM-based workflow generation. TIAgent provides a foundation for making complex CPath workflow construction more accessible while enabling systematic evaluation of LLM-driven scientific workflow generation.

0.20

Nanopath: Fast, Fair, Open Experimentation for Pathology Foundation Models

cs.CV q-bio.TO ·2026-11-04 ·Paul S. Scotti, Hassan Muhammad, Ryan Kim, Nima Ashjaee, Ratna Sagari Grandhi +7 more
publishedbenchmarkcode/data similarity 0.66
Abstract · 17 pages, 2 figures, 10 tables. NeurIPS 2026 workshop: AI at Scale for Clinical Impact: Cancer Pathology Foundation Models

We introduce nanopath, an open-source framework and benchmark for rapidly training and evaluating small-scale pathology foundation models. Using a single H100 GPU, a typical nanopath model trains in a little over an hour on up to one million TCGA pathology tile presentations and evaluates within 25 minutes on a broad suite of tile-level and slide-level tasks. Nanopath enables rapid exploration of research ideas at small scale, so promising training recipes can subsequently be tested with more data and compute. To enable fair comparisons between ideas, we constrain submissions to fixed data and compute budgets while keeping the downstream evaluation protocol fixed. Anyone may clone the codebase, automatically download the data, reproduce or modify existing models, and submit a run to Labless, our public experiment ledger where researchers and AI agents can search through prior attempts. Since its public release in June 2026, nanopath has received 1,269 experiments from 20 contributors. Here, we detail its design and assess how well its rapid evaluation tracks standardized THUNDER, HEST, and PathoBench (CPTAC) benchmarks across six nanopath and 14 reference foundation models. Nanopath's fast evaluation suite strongly tracked these standardized benchmarks, and a few 22M parameter nanopath models even outperformed giant 1.1B parameter models on a subset of downstream tasks. We subsequently discuss how we have since optimized nanopath's evaluation suite to be an even more faithful, quick proxy for external benchmarking. Nanopath provides an accessible testbed for students, researchers, and AI agents to explore pathology foundation modeling through fair, transparent, and directly comparable experiments.

0.39

EviDx: Evidence-Aware Active Diagnosis with Scaffolded LLM Agents

cs.AI ·2026-08-25 ·Lihang Zeng, Shaoting Zhang, Xiaofan Zhang
top venue similarity 0.66
Abstract

Clinical diagnosis is an active evidence-seeking process in which clinicians acquire evidence, update competing hypotheses, and decide when the available evidence is sufficient for diagnosis. Yet many medical diagnosis systems built around large language models (LLMs) still formulate diagnosis as static case-to-answer prediction, with limited support for evidence acquisition. Agentic LLMs offer a dynamic alternative through tool use and intermediate diagnostic trajectories, but existing systems often under-specify how patient evidence should be exposed, scaffolded, and controlled at runtime. We introduce EviDx, an evidence-aware active diagnosis framework that pairs patient-specific diagnostic environments with a clinical diagnostic scaffold and an observer-guided runtime harness. In EviDx, $\mathcal{E}$-Synthesis constructs interactive environments from raw clinical cases; the scaffold organizes role-specialized agents, evidence tools, and evolving evidence states; and the harness regulates diagnostic termination by tracking uncertainty and evidence coverage. A 3-level evaluation pyramid assesses execution robustness, reasoning dynamics, and diagnostic outcomes. Experiments show that EviDx improves diagnostic performance and process stability while revealing model-dependent capability boundaries.

0.60

Explainable Artificial Intelligence (XAI) in Computational Pathology: Definitions, Taxonomy, and Recommendations

cs.AI cs.CV ·2026-08-28 ·Shubham Innani, Suhang You, Adam Shephard, Bhakti Baheti, Francesco Ciompi +11 more
published similarity 0.64
Abstract · On behalf of MICCAI SIG-CompPath. More information: https://miccai.org/index.php/special-interest-groups/sig-comppath/

Computational pathology (CompPath) is transforming medicine by leveraging artificial intelligence (AI) algorithms to support diagnosis, prognosis, and treatment prediction from gigapixel whole-slide images. Clinical adoption is progressing, but is constrained by concerns about safety, accountability, and regulatory oversight in high-stakes clinical environments. Explainable AI (XAI) systems hold promise for building trust and enabling verification, yet the literature remains fragmented due to inconsistent terminology, overlapping methodological families, ad hoc validation, and current reviews. This review aims to formalize XAI methods in CompPath through the: i) introduction of a pathology-centric vocabulary comprising seven core terms; ii) development of a taxonomy across methodological families and three orthogonal axes (stage, type, scope); and iii) establishment of a task-driven framework that maps five clinical questions to recommended methods, method evaluation, and deployment context. Five key gaps between current XAI capabilities and clinical deployment are identified, and actionable steps are proposed to advance XAI for CompPath.

0.42

Can Agentic Systems Close the Gap in Radiology with Production AI Tools?

cs.AI cs.LG ·2026-11-06 ·Aubin Charley, Julien Khlaut, Charles Corbière, Pierre Manceron, Corentin Dancette +1 more
similarity 0.64
Abstract

Radiology AI has developed along two paths: specialized models that perform well on narrow tasks but cover few clinical findings, and generalist models that address a broader range of tasks but remain prone to hallucination and inaccurate measurements. Combining the two through agentic systems offers a route towards comprehensive radiology reporting, but published systems are tied to one modality or body part. We describe a radiology agentic framework that standardizes how an orchestrator calls modular tools to produce a structured report, and use it to measure what such a system can do with the tools from FDA-cleared radiology AI devices. Report generation is simulated on a large multi-modality report corpus, with the orchestrator given either a catalog of finding classes consolidated from the cleared devices, each available on the modalities it is cleared for, or an unlimited catalog in which any class can be requested, and planning either from the clinical indication or from the target report. Tool outputs are simulated from the reference report, so the comparison isolates tool availability and orchestration from tool error. With the cleared catalog and the indication alone, the orchestrator recovers under a third of the clinically actionable findings; recovery improves substantially with the unlimited catalog, and further when the plan is written from the target report. Attributing every missed finding to a cause shows that most are classes no cleared device offers for the study's modality, and that a third are classes or tools that were offered and not called. Adding the most frequently missing tools closes most of the gap to the unlimited catalog on held-out reports, whereas a smaller orchestrator with the unlimited catalog gives up the whole gain. Tool availability and effective orchestration are thus complementary constraints on comprehensive AI-assisted radiology reporting.

0.11

OSWorld-Science: A Benchmark of Computer Use Agents for Learning and Using Scientific Software

cs.AI ·2026-09-30 ·Dingyuan Dai, Heli Qi, Lei Liu, Yinxi Li, Baiding Chen +26 more
benchmark similarity 0.64
Abstract · 62 pages. Website: https://discoailab.github.io/osworld-science-page/ Public contributions welcome: https://forms.gle/htxY5snyANJ4moVEA

Scientific software presents a demanding test for computer-using agents based on visual language models (VLMs): completing a research workflow requires interpreting specialized interfaces, manipulating scientific objects, and producing verifiable results. We thus introduce OSWorld-Science, a benchmark and evaluation environment that combines scientifically meaningful tasks, artifact-based evaluation, and an efficient agent harness for studying computer use in the scientific domain. The benchmark contains 12 VLMs and 146 high-quality tasks across several scientific domains and software configurations, covering workflows such as molecular drawing and retrosynthesis, pathology image analysis, statistical computing, and physical simulation. Tasks are developed through expert proposals and iterative human--AI co-design, with selection guided by scientific value and difficulty. Task-specific execution-based evaluators inspect application states and generated artifacts, including molecular structures, segmentation masks, plots, and numerical results, and award partial credit for incomplete outcomes. Our special harness integrates model adapters, interaction-loop control, and trajectory logging to support comparisons of models and interaction strategies. Our results show that current state-of-the-art VLMs with a strong harness still face challenges in addressing key questions in the scientific domains. We also analyze the benchmarking results across multi-linguistics, reasoning efforts, context length and other factors and derive several important conclusions and directions to assist future development. Overall, we provide an integrated framework connecting expert-defined scientific goals to verifiable software outcomes, enabling systematic evaluation of both agent capabilities and harness design in scientific workflows.

0.28

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

cs.AI cs.HC ·2026-08-31 ·Paulius Mui, Dean F. Sittig, Steve Labkoff, Sanjay Basu
similarity 0.62
Abstract

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.

0.13

LabFactory: Building and Evaluating Executable AI Labs

cs.LG ·2026-09-23 ·Jinge Wu, Hongjian Zhou, Mingde Zeng, Jiayuan Zhu, Junde Wu +2 more
similarity 0.62
Abstract

Scientific tasks specify a desired capability, but realizing it often requires building a computational system tailored to the task---acquiring data, designing representations, training models, implementing tools, and deciding how they are used at inference. We present, a framework in which an AI builder turns a scientific brief into an executable AI lab: a task-specific solver that integrates models, knowledge resources, tools, and a controller behind a fixed interface. The builder develops and packages the lab in a metered workspace; a separate host then executes the delivered artifact on held-out inputs, with reference labels kept outside the solver's input interface, and scores its outputs under the task's protocol. This makes the delivered system, rather than the builder's account of its progress, the object of evaluation. We document 10 selected constructions across six scientific task categories---from molecular and genomic prediction to medical imaging, clinical decision support, and biomedical text---whose delivered labs exceeded their configured reference values on all 12 subtests under host-side execution. Four contain predictive models fitted during construction; the others assemble executable analysis environments, knowledge resources, and tool-driven workflows around a fixed platform LLM. Together they show that an AI agent can carry a scientific brief all the way to a working lab that can still be invoked, inspected, and checked after construction ends.

0.20